Published in
American Association for the Advancement of Science, Science Translational Medicine, 584(13), 2021
DOI: 10.1126/scitranslmed.abd3595
Links
Tools
TCR β chain–directed bispecific antibodies for the treatment of T cell cancers
Journal article published in 2021 by
Suman Paul 
,
Alexander H. Pearlman ,
Jacqueline Douglass ,
Brian J. Mog ,
Emily Han-Chung Hsiue ,
Michael S. Hwang,
Sarah R. DiNapoli ,
Maximilian F. Konig ,
Patrick A. Brown ,
Katharine M. Wright ,
Surojit Sur,
Sandra B. Gabelli ,
Yana Li ,
Gabriel Ghiaur ,
Drew M. Pardoll
and other authors.
,
Alexander H. Pearlman ,
Jacqueline Douglass ,
Brian J. Mog ,
Emily Han-Chung Hsiue ,
Michael S. Hwang,
Sarah R. DiNapoli ,
Maximilian F. Konig ,
Patrick A. Brown ,
Katharine M. Wright ,
Surojit Sur,
Sandra B. Gabelli ,
Yana Li ,
Gabriel Ghiaur ,
Drew M. Pardoll
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Bispecific antibodies directed against T cell receptor β chains promote killing of human T cell cancers while preserving most healthy T cells.